Patents Assigned to SageMedic Corporation
  • Patent number: 11726039
    Abstract: Provided are methods, for selectively analyzing a cell sample. Viable cells are dyed with a membrane-permeable fluorescent dye, and nonviable cells are dyed with a membrane-impermeable fluorescent quenching dye. The cells are illuminated to cause fluorescent emission from the membrane-permeable fluorescent dye in the viable cells and the membrane-impermeable fluorescent quenching dye in the non-viable cells. The cells are then quenched for at least a portion of fluorescence of the membrane-permeable fluorescent dye in the nonviable cells by the membrane-impermeable fluorescent quenching dye. The cells are then analyzed for viable and nonviable cells.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: August 15, 2023
    Assignee: SageMedic Corporation
    Inventors: Ekaterina Moroz, Christian Apfel, Kraig K. Anderson
  • Patent number: 10883936
    Abstract: Provided are methods, for selectively analyzing a cell sample. Viable cells are dyed with a membrane-permeable fluorescent dye, and nonviable cells are dyed with a membrane-impermeable fluorescent quenching dye. The cells are illuminated to cause fluorescent emission from the membrane-permeable fluorescent dye in the viable cells and the membrane-impermeable fluorescent quenching dye in the non-viable cells. The cells are then quenched for at least a portion of fluorescence of the membrane-permeable fluorescent dye in the nonviable cells by the membrane-impermeable fluorescent quenching dye. The cells are then analyzed for viable and nonviable cells.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: January 5, 2021
    Assignee: SageMedic Corporation
    Inventors: Ekaterina Moroz, Christian Apfel, Kraig K. Anderson
  • Patent number: 10564100
    Abstract: Provided are methods, for selectively analyzing a cell sample. Viable cells are dyed with a membrane-permeable fluorescent dye, and nonviable cells are dyed with a membrane-impermeable fluorescent quenching dye. The cells are illuminated to cause fluorescent emission from the membrane-permeable fluorescent dye in the viable cells and the membrane-impermeable fluorescent quenching dye in the non-viable cells. The cells are then quenched for at least a portion of fluorescence of the membrane-permeable fluorescent dye in the nonviable cells by the membrane-impermeable fluorescent quenching dye. The cells are then analyzed for viable and nonviable cells.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: February 18, 2020
    Assignee: SageMedic Corporation
    Inventors: Ekaterina Moroz, Christian Apfel, Kraig K. Anderson